Innovative eye drop may reduce glasses need

The U.S. Food and Drug Administration has approved the new eye drop Vizz, developed by LENZ Therapeutics, to treat age-related vision decline. The drop targets presbyopia, a condition that affects people over 40, and helps improve near vision by constricting the pupil, which enhances visual clarity for up to 10 hours after use. Clinical trials showed that 71% of participants experienced improved vision within half an hour, with no serious side effects reported.

articleDetails.fontSize.sizeحجم النص

تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي

عرض المقال بالكامل